Valeo Pharma IncTSX:VPHView on OTCQB
- LAST PRICE0.1100
- TODAY'S CHANGE (%)0.0100 (10.0000%)
- Bid / Lots0.1100/ 10
- Ask / Lots0.1200/ 46
- Open / Previous Close0.1100 / 0.1000
- Day Range
- 52 Week Range
- Volume12,400
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VPH |
|---|---|---|
| 09:41 ET | 1000 | 0.11 |
| 10:06 ET | 3000 | 0.11 |
| 10:12 ET | 1000 | 0.11 |
| 12:16 ET | 1500 | 0.105 |
| 12:48 ET | 1000 | 0.11 |
| 03:20 ET | 3500 | 0.11 |
| 03:52 ET | 500 | 0.11 |
Apr 25, 2024
Press Release: VALEO PHARMA ANNOUNCES RESULTS OF ANNUAL MEETING OF SHAREHOLDERS, from 5:55PM ET on Thursday Apr 25, 2024 by Dow Jones
5:55PM ET on Thursday Apr 25, 2024 by Dow Jones
Apr 9, 2024
VALEO PHARMA TO PRESENT AT THE 2024 BLOOM BURTON & CO HEALTHCARE INVESTOR CONFERENCE, from 7:00AM ET on Tuesday Apr 09, 2024 by Dow Jones
7:00AM ET on Tuesday Apr 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Valeo Pharma Inc | 9.9M | -0.3x | --- |
Delta 9 Cannabis Inc | 5.2M | -0.3x | --- |
Crescita Therapeutics Inc | 8.4M | -4.4x | --- |
Bhang Inc | 5.1M | -0.7x | --- |
Avricore Health Inc | 13.0M | -15.3x | --- |
Voyageur Pharmaceuticals Ltd | 6.9M | -5.5x | --- |
Company Information
Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler, Atectura Breezhaler and Allerject. The ophthalmology products include Xiidra and Simbrinza. Its specialty products include Redesca, Onstryv, M-Eslon, Yondelis and Ametop Gel 4%. The Company's wholly owned subsidiary is VPI Pharmaceuticals Inc.
Contact Information
- Headquarters
- 16667 Hymus BlvdKIRKLAND, QC, Canada H9H 4R9
- Phone
- 514-693-8832
- Fax
- 514-693-8832
Executives
- Chairman of the Board
- Richard MacKay
- President, Chief Executive Officer, Director
- Steven Saviuk
- Chief Financial Officer, Senior Vice President
- Luc Mainville
- Senior Vice President - Scientific and Medical Affairs
- Nelly Komari
- Senior Vice President, Chief Commercial Officer
- Kyle Steiger
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $9.9M |
|---|---|
Revenue (TTM) | $54.3M |
Shares Outstanding | 98.7M |
Valeo Pharma Inc does not pay a dividend. | |
Beta | 2.57 |
EPS | $-0.33 |
Book Value | $-0.41 |
P/E Ratio | -0.3x |
Price/Sales (TTM) | 0.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -33.58% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
